Market Research Blog – Page 15935 – New Product Development

Stereotactic Planning Software Spending Analysis Market Was estimated to be US$ 252.6 Mn in 2021, with a market CAGR of 4.6% during the forecast period (2021-2031)

Stereotactic planning software is an interactive software tool used in stereotactic planning applications of recording chamber placement and electrode trajectories. It combines basic trajectory planning to obtain arc settings with advanced planning capabilities that improve O.R. workflows, localization of functional areas, and deep brain stimulation (DBS). According to the recent Future Market Insights (FMI) report, the global stereotactic planning software spending analysis is estimated to be US$ 252.6 Mn in 2021, with a market CAGR of 4.6% during the forecast period (2021-2031).

The high prevalence of neurological disorders and small cell lung cancer is expected to boost the demand in the stereotactic planning software market. For instance, Parkinson’s disease and other movement disorders are estimated to affect 2.75 million people in the United States. According to DALY’s, in the U.S., stroke accounts for 3.58 Mn people, Alzheimer’s disease for 2.55 Mn, and migraine for 2.4 Mn.

Furthermore, increasing investments in better treatment options involving precision and artificial intelligence in the software provide impetus to the market by increasing the overall adoption rate. Patients are inclined towards safer and better treatment facilities with minimal incision. Stereotactic planning software facilitates surgeons to plan stereotactic surgery efficiently.

However, the unprecedented impact of the ongoing covid-19 pandemic has created a significant impact on the stereotactic planning software market due to a shortage of inpatient footfalls in hospitals and other centers.

Preference now is being given to the treatment of COVID-19 patients, thus halting product launches for stereotactic planning. Also, this has led to the postponement of the enrolment of the new participants is such studies. Now, with the availability and commencement of the COVID-19 vaccination, the research activities expected to resume in the near future.

Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6452

Key Takeaways from Stereotactic Planning Software Spending Analysis Market Study

Integrated stereotactic planning solutions are expected to grow 2x by 2031 as compared to 2021 owing to ease of use and higher adoption rates.
CT scans are projected to capture over 46% of the global market by 2031. This is attributed to inherent accuracy in identifying and localizing intracranial lesions.
North America is the largest revenue-generating region for stereotactic planning software, with the U.S. accounting for over 79% of the regional market.
The U.K. holds the lead in Europe, accounting for over 37% of the region through the end of 2031.
East Asia is poised to grow at the highest CAGR of 5.3% during the forecast period with China accounting for over 62% of the market owing to the large subclinical patient pool of patients.

Growing cases of neurological disorders, small cell lung cancer, and prostate cancer, along with an increase in patient awareness and screening, favorable reimbursement scenarios, approvals, and grants for product development are factors influencing market growth. The implementation of artificial intelligence, the use of visual improvements in real-time are some of the upcoming trends that are expected to create growth opportunities for manufacturers through the assessment period,” says the FMI Analyst

Any Queries, Contact us @ https://www.futuremarketinsights.com/ask-question/rep-gb-6452

Who is Winning?

Some of the leading companies operating in the stereotactic planning software spending analysis market are focusing on collaborations and mergers and acquisitions for global expansion options with a focus on emerging economies. Thus, enhancing their market presence. For instance,

In March 2021, RaySearch Laboratories AB (publ) announced a sales agent agreement with Canon Medical Systems USA, Inc., enabling RaySearch America’s salesforce to promote Canon Medical’s Aquilion Large Bore CT and Celesteion PET/CT products.
In March 2021, Brainlab announced the acquisition of Mint Medical GmbH. The acquisition aims to improve the structured diagnosis, analysis, and treatment of cancer and other diseases to address the demands of modern medicine and personalized treatments.

The key market players covered by FMI include Brainlab, Inc., Renishaw Inc., Inomed Inc., RaySearch Americas, Inc., Mevis Informática Médica, FHC, Inc., Integra LifeSciences Corporation, Elekta Solutions AB, and SurgiFRONT Ltd.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Femtech Market Trends, Growth, Future Demand, Analysis and Forecast by 2031

Femtech is a term used for female technology which involves the use of digital health tools including software, diagnostics, products, and services that are targeted at women’s health. According to a recent Future Market Insights (FMI) report, the global femtech market is estimated to hit a valuation of US$ 948.1 Mn in 2021, with a market CAGR of 15.0% during the forecast period (2021-2031).

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-11761

Market demand is set to rise at a steady pace throughout the forecast period, majorly favoured by investments outside the boundaries of healthcare towards a branched approach involving domains such as workplace regulations, financial equity, and state legislation.

The primary factor supporting the femtech market to positive expansion in terms of growth and stability is the advent of digitalization and artificial intelligence. Technological advancements such as cloud-based informatics allow personalized solutions, driven by consumer input. This has given rise to affordable and accessible analysis in terms of personal health monitoring and diagnosis.

Key market players have pushed for innovation and accessibility into customized digital solutions. This also includes the introduction of hands-free wearables which are assistive with the regular, day-to-day life of women across the globe.

Additionally, leading product developers in the femtech market work through commercial partners such as department stores, big-box retailers, hospitals, clinics, insurance companies, pharmacies and drugstores, private medical practices and e-commerce platforms to expand product sales prospects.

Key Takeaways from Femtech Market Study

Menstrual health applications will drive market growth holding around a third of the market, supported by growing purchases from the working women demographic.
Diagnostic services are projected to cover about 45% of the global market by 2031. This is aided by the growing accessibility of digital health services
The U.S. holds a dominant share, valuing at over US$ 357.1 Mn by the end of 2021, supported by the presence of leading players and higher consumer acceptance.
The U.K. and Germany dominate the Europe market, cumulatively accounting for more than 25% of the regional revenue.
China is a leading market in East Asia, and is forecast to account for more than 50% of the regional value share owing to a vast consumer base.

“The advent of technological improvements in healthcare in the form of devices, applications, services, and products has increased the rate of diagnosis of reproductive disorders in terms of time management and treatments for women. This will aid growth through the upcoming decade,” says the FMI Analyst

Who is Winning?

Some of the leading companies operating in the femtech market are focusing on collaborations with leading institutions for increasing awareness among the population about the adoption of digital health services.

Collaborations with key pharmaceutical companies to launch customized products and services for the growing consumer base has led key players to retain their position in the market while expanding their product portfolio.

Research collaboration in monitoring fetal heart rates through wearable ECG chips by between Bloomlife and Imec in 2019 has expectantly given rise to superior monitoring capabilities in maternity care.
Femtech companies have integrated applications for tracking fertility and offer services such as in-vitro fertilization. Additionally, they also offer medical treatments and products such as wearables and hands-free devices.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-11761

Key market players covered by FMI include Clue, Aparito Limited, Bloomlife, Bonzun Health Information AB, Elvie, Ava Science Inc., Grace Health, iBreve, LactApp, Natural Cycles Nordic AB, Hera Med Ltd., Niramai Health, NURX Inc., SteadySense GmbH, Pregnolia AG, Willow, WOOM and B-wom.

Microneedle Drug Delivery Systems Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030

Emerging applications of microneedle drug delivery systems are expected to fuel their demand over the next decade. According to a recent report published by Future Market Insights (FMI), the global microneedle drug delivery systems market will grow at a CAGR of 6.6% between 2020 and 2030. The market is witnessing surging demand in the field of pharmacy and cosmetics.

The rising incidence of diseases such as cancer, diabetes, migraine, and others and the need to accurately administer medications are driving the market. Additionally, the demand for minimally invasive and painless treatment methods is expected to bode well for the market.

The report uncovers hidden growth opportunities. It also highlights potential threats to the market players. Some of the key takeaways from the report are highlighted below.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-2750

Key Takeaways from the Report

Solid microneedles are expected to lead the market during forecast period of 2020-2030 among product type
Hospitals are the leading end users of microneedle drug delivery systems, with specialty clinics gaining popularity.
Specialty clinics are expected to grow at an accelerated rate as one of the key end users of microneedle drug delivery systems
North America is the largest market for microneedle drug delivery systems. Along with Europe, it is expected to cover more than 70% of the market by end of 2030.
East Asia is expected to be the fastest growing regional market during the next decade.

Covid 19 Restricting Pace of Growth

The onset of pandemic has disturbed the entire business ecosystem. With productions coming to a halt and supply chains disrupted due to lack of transport, manufacturers of microneedle drug delivery systems are impacted in a big way.

Also, because of several restrictions by governments like social distancing, doctors and practitioners are choosing to avoid any surgical treatments which are not absolutely and immediately necessary.

Furthermore, cosmetic field which is another major user of microneedle drug delivery systems is also impacted as almost all treatments under their umbrella are considered to be not urgent.

Who is winning?

The key market players in microneedle drug delivery systems market include the 3M Company, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas co. ltd., Nanopass Tech, Corium International, Inc., Valeritas, Inc., Nitto Denko Corporation, Microdermics, Inc., TheraJect Inc., Vaxxas Pty Ltd., Endoderma Ltd., QuadMedicine, SNvia Co., Ltd., Small Lab and AdminMed Nano BioSciences LLC

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-2750

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Lacrimal Duct Stent Tube Market to Grow at Robust CAGR by 2029

Introduction of upgraded and highly precise lacrimal duct stent tube for canalicular stenosis or obstruction and congenital nasolacrimal duct obstruction remains a key booster to the growth of lacrimal duct stent tube market. The global market for lacrimal duct stent tube is projected for a promising 6% CAGR during 2019 – 2029, as suggested by a new Future Market Insights (FMI) report.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-9649

There has been higher preference for bicanalicular lacrimal duct stent tube over its monocanalicular counterpart, attributing to the former’s high success rate, suitability for stenting in older patients, and better clinical outcomes. Moreover, increasing prevalence of retina-related conditions, primarily imperforation of nasolacrimal duct, epiphora both in infants and adults, and conditions necessitating dacryocystorhinostomy are other factors responsible for propelling revenue growth of the lacrimal duct stent tube market.

Consistent efforts towards diagnosis and management of lacrimal duct obstruction with enhanced success rate, minimally invasive lacrimal surgery, and better clinical outcomes, and increasing product awareness among ophthalmologist are factors augmenting growth prospects for the lacrimal duct stent tube market.

Key Takeaways – Lacrimal Duct Stent Tube Market Study

Bicanalicular lacrimal duct stent tube is expected to contribute three fourth of revenue share in the lacrimal duct stent tube market owing to its high success rate in stent placement.
Hospitals captured maximum share of the lacrimal duct stent tube market owing to highest patient footfall followed by ophthalmic clinics.
Attributed to growing patient pool for retinal diseases, especially due to premature births, contributed to the dominance of North America in the lacrimal duct stent tube market.
Increasing awareness for availability of the treatment for nasolacrimal duct stent obstruction among caregivers of prematurely born babies and increasing number of skilled professionals are expected to drive growth of the lacrimal duct stent tube market in East Asia.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-9649

Manufacturers Emphasizing Advanced Product Development

Numerous organizations are focusing on new product development for lacrimal duct stent tube. In June 2019, FCI Ophthalmic offered a complete line of BIKA stents namely, BIKA, BIKA for DCR, and Infant BIKA covering a range of sizes that will benefit most of the congenital nasolacrimal duct obstruction (CNLDO) and dacryocystorhinostomy (DCR) cases.

Digital Wound Measurement Devices Market Perspective, Comprehensive Analysis, Growth and Forecast 2020-2030

Wound care measurement has been acquiring immense significance in recent years. Growing incidences of traumatic injuries due to accidents and prevalence of chronic diseases such as diabetes mellitus are primary growth stimulants. Healthcare industries worldwide are adopting technologically enhanced wound management systems to provide quality care solutions to patients. As a result, digital wound measurement devices market is gaining steady ground.

Biosensors are being extensively incorporated as they are highly effective in providing critical data regarding bacterial colonization, oxygen, glucose and pH levels at the wound site, enabling doctors to diagnose and treat wounds accordingly. Several universities and institutions are augmenting their research capabilities to conduct further studies on biosensor-enabled devices.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-717

Digital Wound Measurement Devices Market- Key Takeaways

A CAGR of 4.5% is projected for the forecast period ranging from 2020-2030
Rising smartphone and IoT device ownership is deepening telehealth penetration, providing traction to the market
Diabetic ulcers to account for the lion’s share owing to increasing prevalence of diabetes mellitus
North America to lay suzerainty over the global market, capturing over 40% market share
New product launches and collaborations constitute primary market expansion strategies of prominent vendors

COVID-19 Impact Analysis

The wound care market has been impacted by the coronavirus pandemic, and is anticipated to experience a moderate slowdown in growth through 2021, attributed to a decline in surgical procedures. However, the chronic wound patient pool will continue requiring treatment, ushering in a consistent revenue stream for chronic wound devices.

Practitioners are exploring opportunities to incorporate digital wound measurement devices to treat COVID-19 patients, primarily to provide relief from lung inflammation by checking and curtailing the secretion of interleukin-6, a pro-inflammatory cytokine.

Demand for homecare wound measurement devices has spiked, attributed to increase in home visit frequencies across countries for patients suffering from chronic conditions. All these factors are expected to have a considerable influence on the market’s growth trajectory in the short-term forecast period.

Digital Wound Measurement Devices Market- Competitive Landscape

Prominent players within the digital wound measurement devices landscape include Perceptive Solutions Inc., ARANZ Medical, Smith & Nephew plc, WoundVision Inc., WoundMatrix Inc., KCI, Parable Health, Hitachi Healthcare Americas, 3M Company and WoundRight Technologies.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-717

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Ophthalmic Tonometers Market Trend 2020, Growth, Leading Companies with Impact of Covid-19, Business Scenario, Emerging Dynamics, Industry Share and Revenue Forecast by 2030

Driven by recent technological advancements and rising cases of diabetes the ophthalmic tonometers market is forecast to expand considerably. According to Future Market Insights (FMI), the global ophthalmic tonometers market size is expected to reach US$ 445.5 Mn by the end of 2030.

As per the National Diabetes Report 2020 by CDC, 10.5 % of the U.S. population are diabetic. As a result a large portion of the population is prone to glaucoma. Ophthalmic tonometers are widely used by eye-specialists for eye test to check for the risk of glaucoma and hence the market growth is increasing in the present scenario.

Though the recent COVID-19 pandemic is affecting the current year market revenue, the global ophthalmic tonometers market is expected to grow further over the forecast period. The rising focus towards health and willingness to spend on advanced healthcare will enable growth in the market.

The FMI report offers an in-depth and unbiased analysis of the global ophthalmic tonometers market during the forecast period.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12687

Some of the key takeaways from the report are given below-

The global ophthalmic tonometers market value is anticipated to grow by 4.8% CAGR during the forecast period from the year 2020 to 2030
Due to the rising cases of diabetes around the world, people are getting more vulnerable to glaucoma resulting in increased market demand
The advent of substitutes to measure intraocular pressure is expected to come in the way of market growth in the coming years
The increase in disposable prism development to minimize the infection spread while administering glaucoma patients will cater to the market demand in coming years
The increased awareness among people for earlier diagnosis and routine monitoring of intraocular pressure (IOP) to prevent permanent vision loss is expected to catalyze the market growth

Rising Demand for Advanced Technologies across Healthcare Facilities

As the key end-user industries such as hospitals, ophthalmic diagnostic centers and others are getting equipped with modern facilities, growth witnessed by the market is expected to continue throughout the forecast period. Also, the advent of disposable prism to prevent the diagnosis-related infection, is catering to the market growth.

Being an integral part of ophthalmic treatment, tonometers have evolved significantly over the years starting from a desktop held device to a smart handheld one. In order to measure the intraocular pressure for precise diagnosis for eye treatment, ophthalmic tonometers are utterly important and as a result the market demand is getting sky-high gradually.

COVID-19 Impact Analysis

Due to the COVID-19 pandemic the market demand has been witnessing sluggish growth as focus in general has shifted towards the emergency treatment due to the virus outbreak.

Furthermore, the shut downs of manufacturing units for long time, unavailability of labors, scarcity of raw materials and other factors have declined the market growth.

According to FMI, these restraining factors due to COVID-19 is expected to slow down the growth rate till the first quarter of 2021.

Despite of the negative effects of COVID-19, the global ophthalmic tonometers market is anticipated to exhibit steady growth during the forecast period.

Who is winning?

Impressive growth exhibited by the ophthalmic tonometers market will creative lucrative prospects for companies operating therein. To capitalize on it key market players such as Nidek, Jorgensen Laboratories, Topcon, Photon Surgical Systems Ltd., and others are launching advanced products along with adopting long-term strategic plans.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-12687

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Polyether Ether Ketone (PEEK) Interbody Devices Market Analysis (COVID-19 Analysis) – Industry Insights, Drivers, Top Trends, Global Analysis, Forecast and Opportunities to 2030

Future Market Insights (FMI), in a recent report estimates global PEEK interbody devices market to grow steadily through 2021, despite COVID-19 pandemic creating a shift in administered care. The study pegs growth to hover above 7% mark throughout the forecast period.

Polyether ether ketone interbody devices are a significant breakthrough in the medical industry, with various healthcare settings adopting them to streamline their spinal implantation procedures. Additionally, they are highly eco-friendly as they are manufactured from organic thermoplastic polymers.

Provision of a bone-like modulus, high radiolucency to ensure accuracy and greater biocompatibility have all contributed to increasing PEEK interbody devices adoption for spinal procedures, and is likely to remain so in the future.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12685

Key Takeaways

US to retain market dominance; East Asia to be 2^nd largest market through 2030
Surging popularity of minimally invasive surgeries to escalate interbody fusion devices growth
Hospitals to be key PEEK interbody devices end-users from 2020-2030
Rapid advancements in spinal implants to facilitate greater adoption
Fast-track regulatory approvals expanding sales across prominent regions
Global PEEK interbody devices to expand at 7.7% CAGR through 2030

COVID-19 Impact Insights

The novel coronavirus pandemic has had varying impacts across the global polyether ether ketone interbody devices market. In the first stage, strict lockdowns and social distancing measures led to a drastic decline in industrial output, creating immense shortages of the devices across various healthcare settings.

Furthermore, greater emphasis was laid on caring for COVID-19 positive patients, leading to postponement of elective surgical procedures such as spinal correction or implantation, causing a substantial decline.

As the incidence of infections receded, the market has been experiencing a gradual incline. Flattening infection curves have enabled countries to ease lockdown restrictions, leading to a resumption of output which has largely balanced the demand-supply equation.

Moreover, spinal implant procedures are resuming, with hospitals and clinics registering a fall in the number of SARS-CoV-2 patients. Considering this recovery scenario, the global PEEK interbody devices is anticipated to rebound starting from 2021.

Competition Landscape

Prominent players within the global PEEK interbody devices landscape are Zimmer Biomet, Medtronic Plc, Stryker Corporation and Shandong Weigo Group. These and other players are focusing on expanding existing manufacturing capabilities, product innovations, forays into untapped markets and strengthening core competencies.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-12685

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Stethoscope Market 2020 (COVID-19 Impact Analysis Included) Opportunities, Regional Overview, Top Leaders, Revenue and Forecast to 2030

Stethoscope being an integral part of the modern medical diagnosis sector, has been gaining significant traction. According to a recent study by Future Market Insights, the stethoscope market is forecast to expand at above 5% CAGR between 2020 and 2030.

Stethoscopes are often considered a physician’s third hand and the current digital advancements have ensured better performance.

The key market players such as American Diagnostic Corporation, 3M Company, Eco Devices Inc. and others are investing heavily to offer digitization of various medical tools. They are focusing on technological advancements also gain competitive advantage in the global market. The leading companies have started developing electronic stethoscopes in order to detect critical cardiovascular conditions much earlier than the normal stethoscopes can.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12675

The FMI report offers in-depth research and analysis of the global stethoscope market, its potential and growth scopes during the forecast period (2020-2030).

Some of the key takeaways from the report are as given below-

The global stethoscope market is set to grow by 5.2% CAGR during the forecast period (2020-2030).

Cardiovascular (CVS) disease being the main area of focus for the application of stethoscope in the medical sector, is to remain in the top factors for the increase in market demand
By product acoustic stethoscope will keep leading the global market throughout the forecast period (2020-2030)
Physician office, home care settings, hospitals and others to remain the top end-users catering to the market growth throughout the forecast period. Of these, demand from hospitals is set to be higher
Region-wise North America and Latin America to lead the global market. Europe, South & East Asia, Oceania and MEA to sustain as other region-wise key players.

Rising Focus on Health and Wellbeing Boosting Growth

As people are getting more conscious about their health and well-being, the digitized sectors like stethoscope market is anticipated to expand further during the forecast period, reaching US$ ~ 914 Mn by the end of the year 2030. The recent COVID-19 pandemic has even accelerated the growth of medical diagnosis which is resulting in the steady market growth over the years in future.

Currently the global stethoscope market holds unlimited opportunities for the global market players and so, the dominant market holders have already started adopting various digitized tools and procedure to remain in the top places. For instance, the digital Eko CORE has brought their advanced algorithms which can automatically screen patients and is capable of providing up to 40x amplification of acoustic sound along with advanced noise elimination technology, as well as the modern flexible feature of switching between digital and acoustic modes.

COVID-19 Impact Analysis

Due the outbreak of novel coronavirus during the recent time, the demand of modern digitized stethoscopes has increased across the countries. The pandemic has created more awareness among the people as well as there is surge in the need of getting diagnosed earlier than the other times.

These altogether have increased the global stethoscope market demand among the top end-users, starting from physicians to hospitals or home care providers. As the increased concern regarding health, especially heart and lungs related issues tends to sustain, the COVID-19 impact on the global stethoscope market will be long-lasting, opening endless opportunities to the market players during the forecast period.

Who is winning?

The global stethoscope market being emerged as a highly potential domain for the market dominating companies, the key market holders are evolving by adoption of various modern technologies. The leading Companies like, Think Labs Medical LLC, Rudolf Riester GmbH, Meditech Equipment Co., Ltd. and others have started their research and release of various brand-new products to expand further throughout the forecast period (2020-2030).

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-12675

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Neurology Digital Therapeutics Market is anticipated to witness a 9.0% growth during the forecast period

Neurology digital therapeutics is the field of healthcare that deals with and prevents medical conditions using information and communication technology. According to the recent research by FMI, the neurology digital therapeutics market is anticipated to witness a 9.0% growth during the forecast period from 2021 to 2031. This significant growth will be experienced due to the advancement in technology in the healthcare sector. Therefore, neurology digital therapeutics demand is expected to increase significantly soon.

To remain ‘ahead’ of your competitors, request for a sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-14231

What is Driving Demand for Neurology Digital Therapeutics?

Various factors are driving the demand for neurology digital therapeutics such as it optimizes the time of administrative tasks and routine communication, it reduces the pain associated with the traditional therapeutic methods, it make the monitoring easier and more accurate.

These technologies can also be used for therapy and rehabilitation purposes with the help of smartphones, tablets and computers.

Also, neurological digital therapeutics can overcome various problems related to traditional clinical practices. Thus, all these factors have the potential to drive the demand of the market during the forecast period from 2021 to 2031.

Advancement in Information Technology Likely to Augment Neurology Digital Therapeutics

Information technology work in conjugation with the drugs to give maximum benefit of the treatment to the patients. Patients can take care of their health through easy-to-use apps and monitoring devices. Start-ups are introducing different innovative ideas to attract investors.

Also, the prevalence of chronic diseases is rising in the world that creating opportunities for healthcare and digital therapy players to invest in the market by innovating and launching technological advanced devices and enhance the neurological digital therapeutics demand globally.

The treatment of chronic diseases with the traditional method is becoming a challenging thing for healthcare workers and manufacturers due to its increasing burden. Thus, innovative technology or digital therapeutics is required for the treatment of a large number of populations suffering from chronic diseases.

Thus, it is expected to boost the market of neurology digital therapeutics during the forecast period from 2021 to 2031 in the world.

The U.S. and Canada Neurology Digital Therapeutics Market Outlook

U.S. and Canada remain the predominant market for neurology digital therapeutics because of the presence of key players in the region. For instance, Pear Therapeutics headquartered in the U.S. operates at the intersection of biology and software technology. The company discovers, develops, and delivers clinically certified software to provide better outcomes for patients using neurological digital therapeutics.

Thus, the demand for neurology digital therapeutics will increase in the region during the forecast period from 2021 to 2031.

Europe Demand Outlook for Neurology Digital Therapeutics

The demand for neurology digital therapeutics will be increased in Europe because of a rising number of chronic disease amongst patients with rising geriatric populations in the region.

With increasing age, the chances of developing chronic diseases also increase in the region.

According to EUROSTAT, in 2020, there were 20.6% of people in Europe were more than 65 years of age.

Thus, there will be growth in the neurology digital therapeutics market in the region during the forecast period from 2021 to 2031.

Who are the Key Manufacturers and Suppliers of Neurology Digital Therapeutics?

For critical insights on this market, request to ask an expert here @
https://www.futuremarketinsights.com/ask-question/rep-gb-14231

The key players of neurology digital therapeutics include

Livongo Health
Noom
Omada Health
Pear Therapeutics
WellDoc
Proteus Digital Health
Propeller Health
Akili Interactive Labs
Mango Health
Better Therapeutics
Happify
Kaia Health
Click Therapeutics and others.

They follow certain strategies to survive in the market like a product launch, product approval, patent gaining, expansion, acquisition and merger. For instance, in October 2021, Pear Therapeutics announced about continuing the expansion of intellectual property portfolio for prescription digital therapeutics.

The Report Covers Exhaustive Analysis on:

Neurology Digital Therapeutics market Segments
Neurology Digital Therapeutics market Dynamics
Neurology Digital Therapeutics Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional Analysis Includes:

North America (U.S., Canada)
Latin America ( Brazil, Mexico, Argentina, Rest of Latin America)
Europe (Germany, Italy, UK, Spain, France, Russia, Rest of Europe)
South Asia (India, Indonesia, Malaysia, Thailand, Rest of South Asia)
East Asia (Japan, South Korea, China)
Oceania ( Australia, New Zealand)
The Middle East and Africa (GCC, Turkey, South Africa, Rest Of MEA)

Report Highlights:

Detailed overview of Neurology Digital Therapeutics market
Changing market dynamics in the industry
In-depth Neurology Digital Therapeutics market segmentation
Historical, current and projected market size in terms of volume and value.

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Key Segments

By Product Type:

Software
Devices

By Indication:

Diabetes
Obesity
Cardiovascular Disease (CVD)
Central Nervous System (CNS) Disease
Respiratory Disease
Others

By End User:

Hospital
Clinics
Others

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-14231

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
MEA

Intravenous Pegloticase Market Size, Growth Opportunities, Industry Potential, Segmentation Overview, Trends And Forecast Studies 2030

Intravenous pegloticase is a drug used for the treatment of chronic and refractory gout disease, used for treating the patients who have undergone medications that did not work well. Gout is a disease caused due to excessive uric acid in the blood (hyperuricemia).

Intravenous pegloticase works by lowering the amount of uric acid in the body. Intravenous pegloticase is administered in healthcare settings and healthcare by healthcare providers to manage the adverse events of the drug.

Intravenous pegloticase market is expected to expand during the forecast period due to the increasing prevalence of gout disease across the globe and strong R & D pipelines.

Pandemic coronavirus is believed to have a severe impact on the global intravenous pegloticase market. Intravenous pegloticase market manufacturing industries are being shuttered around the world causing an unprecedented technology and business model transformation.

There has been a disruption in the production and supply of intravenous pegloticase due to the global restrictions. Also, the flow of patients seeking gout treatment in the hospitals and clinics is reduced which is affecting the global intravenous pegloticase market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12462

Intravenous pegloticase Market: Drivers and Restraints-

The increasing prevalence of chronic and refractory gout disease is expected to be the major driver of the intravenous pegloticase growth market. The strong R & D pipelines are another major factor driving the growth of the intravenous pegloticase market.

The increasing mergers and collaborations between major companies and increasing demand for effective treatment of chronic and refractory gout are also driving the growth of the intravenous pegloticase market.

Furthermore, the rising awareness and adoption of intravenous pegloticase in the management of chronic and refractory gout disease, especially in emerging nations is likely to boost the intravenous pegloticase market growth.

However, there are some factors which can restrain the growth of the intravenous pegloticase market such as adverse reactions of the drug associated with its use, including infusion reactions, and anaphylaxis.

Many other adverse events such as gout flare, nausea, contusion, nasopharyngitis chest pain and vomiting have also been reported. Also, the stringent regulations imposed by the authorities restrict the intravenous pegloticase market growth.

Intravenous pegloticase Market: Overview

Based on the age group, the adult segment is expected to hold a major share in the intravenous pegloticase market due to the increasing prevalence of chronic and refractory gout disease among the adult population. Based on the indication, the chronic gout disease segment is expected to dominate the intravenous pegloticase market.

Based on the distribution channel, the hospital pharmacies are expected to be the most profitable segment in the global intravenous pegloticase market due to the higher number of patients flow in the hospitals.

Intravenous pegloticase Market: Region-wise Outlook

North America is expected to dominate the global intravenous pegloticase market, due to the advancement in the treatment of gout diseases and increasing prevalence of chronic and refractory gout disease in the region. North America is expected to be followed by Europe, due to the higher adoption of the drug in the region.

Asia-Pacific is expected to have a significant growth in the global intravenous pegloticase market over the forecast period due to the increasing awareness of intravenous pegloticase usage, and rising healthcare expenditure. Also increasing population in countries like China and India is further likely to boost the intravenous pegloticase market growth in the region.

Intravenous pegloticase Market: Key Market Participants

Some of the market participants in the global intravenous pegloticase market identified across the value chain include:

Horizon Therapeutics
BTG plc
Savient Pharmaceuticals Inc

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-12462

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario